NICE guidance in schizophrenia: How generalisable are drug trials?

Aims and method: To test the National Institute for Clinical Excellence (NICE) assertion that characteristics of participants in the majority of clinical drug trials in schizophrenia do not reflect clinical practice. In particular they were concerned about the relative exclusion of women, older adul...

詳細記述

書誌詳細
第一著者: Burns, T
フォーマット: Journal article
言語:English
出版事項: 2006

類似資料